Post

New UK intracellular drug delivery centre to support RNA development

A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and …

FDA approves Analog and Dipharma’s ANDA for nitisinone capsules

The US Food and Drug Administration (FDA) has granted clearance to Analog Pharma and Dipharma’s abbreviated new drug application (ANDA) …

(Cilnidipine + tadalafil) by AISA Pharma for Raynauds Disease: Likelihood of Approval

(Cilnidipine + tadalafil) is under clinical development by AISA Pharma and currently in Phase II for Raynauds Disease. According to …

RO-7446603 by Genentech USA for Diabetic Macular Edema: Likelihood of Approval

RO-7446603 is under clinical development by Genentech USA and currently in Phase I for Diabetic Macular Edema. According to GlobalData, …

TQB-3454 by Chia Tai Tianqing Pharmaceutical Group for Solid Tumor: Likelihood of Approval

TQB-3454 is under clinical development by Chia Tai Tianqing Pharmaceutical Group and currently in Phase I for Solid Tumor. According …